Strides Pharma Science has enclosed the Un-audited Financial Results (Consolidated and Standalone) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and half year ended September 30, 2025, as approved by the Board of Directors of the Company at their meeting held today i.e., October 31, 2025. The Board Meeting commenced at 11:30 hrs IST and concluded at 12:50 hrs IST. The above information will also be available on the website of the Company at www.strides.com.
The above information is a part of company’s filings submitted to BSE.
